EP3116547
Meðferðar-nanóagnir sem innihalda meðferðarmiðil og aðferðir til framleiðslu og notkunar á þeim
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.3.2015EP published:
5.6.2019EP application number:
15713285.3
EP translation filed:
1.7.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
12.3.2035Expiry date:
12.3.2022
Title:
THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME
Timeline
Today
13.3.2015EP application
5.6.2019EP Publication
1.7.2019Translation submitted
15.7.2019Registration published
12.3.2022Expires
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, 10017, New York, NY, US
Inventor
Name:
BAGRODIA, ShubhaAddress:
San Diego, CA, US
Name:
LAFONTAINE, JenniferAddress:
San Diego, CA, US
Name:
LOVATT, ZachAddress:
Danvers, MA, US
Name:
SHIN, EyoungAddress:
Marlborough, MA, US
Name:
SONG, Young, HoAddress:
Natick, MA, US
Name:
TROIANO, GregAddress:
Pembroke, MA, US
Name:
WANG, HongAddress:
Newton, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461953628 PDate:
14.3.2014Country:
US
Classification
Categories:
A61K 47/12, A61K 47/28, A61K 47/34, A61K 9/107, A61K 9/51, A61K 31/5377
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 3.1.2020
Expires: 12.3.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.2.2021
Expires: 12.3.2022
Payer: Örn Þór slf.